Literature DB >> 22992160

The effect of D-cycloserine on subliminal cue exposure in spider fearful individuals.

Cassidy A Gutner1, Joel Weinberger, Stefan G Hofmann.   

Abstract

Research on D-cycloserine (DCS) has demonstrated a significant effect on symptom reduction in human studies that utilized conventional exposure-based approaches. Recent studies have offered promising results for targeting fears through subliminal paradigms. In this double-blind, randomized placebo-controlled study, 45 spider fearful individuals received DCS or placebo pills prior to completing a subliminal cue exposure task to images of spiders. Participants completed self-report questionnaires and a behavioral approach task to a live caged tarantula. After repeated exposure to subliminal spider cues, participants in the DCS group reported a greater reduction in disgust than individuals in the placebo group. No difference was observed in fear ratings. These findings suggest that DCS augments the reduction in disgust in spider fearful subjects after subliminal exposure to spider cues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22992160      PMCID: PMC3518605          DOI: 10.1080/16506073.2012.711770

Source DB:  PubMed          Journal:  Cogn Behav Ther        ISSN: 1650-6073


  41 in total

1.  Learned fear of "unseen" faces after Pavlovian, observational, and instructed fear.

Authors:  Andreas Olsson; Elizabeth A Phelps
Journal:  Psychol Sci       Date:  2004-12

2.  Disgust, anxiety and fainting symptoms associated with blood-injection-injury fears: a structural model.

Authors:  Bunmi O Olatunji; Nathan L Williams; Craig N Sawchuk; Jeffrey M Lohr
Journal:  J Anxiety Disord       Date:  2005-01-22

Review 3.  Effects of D-cycloserine on extinction: translation from preclinical to clinical work.

Authors:  Michael Davis; Kerry Ressler; Barbara O Rothbaum; Rick Richardson
Journal:  Biol Psychiatry       Date:  2006-08-15       Impact factor: 13.382

4.  A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.

Authors:  Adam J Guastella; Mark R Dadds; Peter F Lovibond; Philip Mitchell; Rick Richardson
Journal:  J Psychiatr Res       Date:  2006-07-10       Impact factor: 4.791

Review 5.  Contributions of the amygdala to emotion processing: from animal models to human behavior.

Authors:  Elizabeth A Phelps; Joseph E LeDoux
Journal:  Neuron       Date:  2005-10-20       Impact factor: 17.173

6.  Disgust and disgust sensitivity in blood-injection-injury and spider phobia.

Authors:  D F Tolin; J M Lohr; C N Sawchuk; T C Lee
Journal:  Behav Res Ther       Date:  1997-10

7.  Differential UCS expectancy bias in spider fearful individuals: evidence toward an association between spiders and disgust-relevant outcomes.

Authors:  Mark van Overveld; Peter J de Jong; Madelon L Peters
Journal:  J Behav Ther Exp Psychiatry       Date:  2005-10-13

8.  Contamination vs. harm-relevant outcome expectancies and covariation bias in spider phobia.

Authors:  Peter J de Jong; Madelon L Peters
Journal:  Behav Res Ther       Date:  2006-11-09

Review 9.  Enhancing exposure-based therapy from a translational research perspective.

Authors:  Stefan G Hofmann
Journal:  Behav Res Ther       Date:  2007-06-17

10.  Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.

Authors:  Stefan G Hofmann; Alicia E Meuret; Jasper A J Smits; Naomi M Simon; Mark H Pollack; Katherine Eisenmenger; Michael Shiekh; Michael W Otto
Journal:  Arch Gen Psychiatry       Date:  2006-03
View more
  4 in total

Review 1.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

Review 2.  Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder.

Authors:  Joseph F McGuire; Adam B Lewin; Eric A Storch
Journal:  Expert Rev Neurother       Date:  2014-06-27       Impact factor: 4.618

Review 3.  Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders.

Authors:  Rasmita Ori; Taryn Amos; Hanna Bergman; Karla Soares-Weiser; Jonathan C Ipser; Dan J Stein
Journal:  Cochrane Database Syst Rev       Date:  2015-05-10

4.  Systematic Review of Studies on Subliminal Exposure to Phobic Stimuli: Integrating Therapeutic Models for Specific Phobias.

Authors:  Sergio Frumento; Danilo Menicucci; Paul Kenneth Hitchcott; Andrea Zaccaro; Angelo Gemignani
Journal:  Front Neurosci       Date:  2021-06-02       Impact factor: 4.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.